Kaitlin E. Browman
Affiliations: | 1998-2000 | Abbott Laboratories, Irving, TX, United States |
Google:
"Kaitlin Browman"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Esbenshade TA, Browman KE, Miller TR, et al. (2012) Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist. The Journal of Pharmacology and Experimental Therapeutics. 343: 233-45 |
| Mohler EG, Browman KE, Roderwald VA, et al. (2011) Acute inhibition of 11beta-hydroxysteroid dehydrogenase type-1 improves memory in rodent models of cognition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 5406-13 |
| Zhang M, Ballard ME, Basso AM, et al. (2011) Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity. Behavioural Brain Research. 217: 81-7 |
| Bitner RS, Bunnelle WH, Decker MW, et al. (2010) In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease. The Journal of Pharmacology and Experimental Therapeutics. 334: 875-86 |
| Rustay NR, Cronin EA, Curzon P, et al. (2010) Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease. Brain Research. 1311: 136-47 |
| Zhao C, Sun M, Bennani YL, et al. (2008) The alkaloid conessine and analogues as potent histamine H3 receptor antagonists. Journal of Medicinal Chemistry. 51: 5423-30 |
| Esbenshade TA, Browman KE, Bitner RS, et al. (2008) The histamine H3 receptor: an attractive target for the treatment of cognitive disorders British Journal of Pharmacology. 154: 1166-1181 |
| Cowart M, Gfesser GA, Browman KE, et al. (2007) Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activity. Biochemical Pharmacology. 73: 1243-55 |
| Ballard ME, Basso AM, Gallagher KB, et al. (2007) The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment. Psychopharmacology. 190: 1-11 |
| Zhang M, Ballard ME, Kohlhaas KL, et al. (2006) Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1382-92 |